Fragment-based drug design (FBDD) has led to a revolution in contemporary drug discovery, facilitating a bottom-up approach to the identification and evolution of bioactive small molecules into viable ...

Fragment-based screening (FBS) by NMR has become a key tool in the pharmaceutical industry for identifying new ligands that bind to specific biological targets. NMR also plays a crucial role in ...